Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Pharmacology

• Publication date

  2008-08-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2008.06.005PMID 18573250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis.

  2008cited by this paper
• Tyrosine kinase and phosphatase regulation of slow delayed‐rectifier K+ current in guinea‐pig ventricular myocytes

  2006cited by this paper
• Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms.

  2006cited by this paper
• Angiotensin II Potentiates the Slow Component of Delayed Rectifier K+ Current via the AT1 Receptor in Guinea Pig Atrial Myocytes

  2006cited by this paper
• Characterization of Recombinant Human Cardiac KCNQ1/KCNE1 Channels (IKs) Stably Expressed in HEK 293 Cells

  2006cited by this paper
• Danshen: An Overview of Its Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use

  2005cited by this paper
• Nontranscriptional Regulation of Cardiac Repolarization Currents by Testosterone

  2005cited by this paper
• Ionic current abnormalities associated with prolonged action potentials in cardiomyocytes from diseased human right ventricles.

  2004cited by this paper
• Unique Kir2.x Properties Determine Regional and Species Differences in the Cardiac Inward Rectifier K+ Current

  2004cited by this paper
• Nitric oxide‐dependent modulation of the delayed rectifier K+ current and the L‐type Ca2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea‐pig cardiomyocytes

  2004cited by this paper
• Pharmacological Activation of Normal and Arrhythmia-Associated Mutant KCNQ1 Potassium Channels

  2003cited by this paper
• Probing the Contribution of IKs to Canine Ventricular Repolarization: Key Role for &bgr;-Adrenergic Receptor Stimulation

  2003cited by this paper
• Requirement of a Macromolecular Signaling Complex for β Adrenergic Receptor Modulation of the KCNQ1-KCNE1 Potassium Channel

  2002cited by this paper
• Serine 331 is the major site of receptor phosphorylation induced by agents that activate protein kinase G in HEK 293 cells overexpressing thromboxane receptor alpha.

  2001cited by this paper
• Inward rectifiers in the heart: an update on I(K1).

  2001cited by this paper
• Left Ventricular Hypertrophy Decreases Slowly but Not Rapidly Activating Delayed Rectifier Potassium Currents of Epicardial and Endocardial Myocytes in Rabbits

  2001cited by this paper
• Functional Analysis of Type 1α cGMP-dependent Protein Kinase Using Green Fluorescent Fusion Proteins*

  2001cited by this paper
• Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.

  2001cited by this paper
• Nitric Oxide Activation of p38 Mitogen-activated Protein Kinase in 293T Fibroblasts Requires cGMP-dependent Protein Kinase*

  2000cited by this paper
• Cyclic GMP-dependent Protein Kinase Activates Cloned BKCa Channels Expressed in Mammalian Cells by Direct Phosphorylation at Serine 1072*

  1999cited by this paper
• Histamine H1‐receptor‐mediated modulation of the delayed rectifier K+ current in guinea‐pig atrial cells: opposite effects on IKs and IKr

  1999cited by this paper
• A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents.

  1998cited by this paper
• Independent and exclusive modulation of cardiac delayed rectifying K+ current by protein kinase C and protein kinase A.

  1998cited by this paper
• Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle.

  1998cited by this paper
• Potassium channel down-regulation in heart failure.

  1998cited by this paper
• Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel

  1996cited by this paper
• Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.

  1996cited by this paper
• KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current

  1996cited by this paper
• Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action.

  1991cited by this paper
• [Effects of intracoronary injections of sodium tanshinone II-A sulfonate and dipyridamole on myocardial infarct size in acute ischemic dogs (author's transl)].

  1981cited by this paper

• Lumacaftor and fexofenadine prevent donepezil-induced LQTS via PHE656-mediated hERG chaperoning.

  2026cites this paper
• Harnessing the therapeutic value of Tanshinone IIA: a breakthrough therapy in cardiovascular diseases

  2025cites this paper
• Functions of the KCNE Gene Family in Ion Channels.

  2025cites this paper
• Traditional Chinese Medicine for Anti‐Arrhythmias: Mechanisms via Potassium Channels

  2025cites this paper
• A universal, accurate natural compounds evaluation platform via cardiomyocyte based biosensing

  2025cites this paper
• Chinese herbal medicine for the treatment of cardiovascular diseases ─ targeting cardiac ion channels.

  2023cites this paper
• Suxiao Jiuxin Pills Prevent Ventricular Fibrillation from Inhibiting L-type Calcium Currents CaV1.2 in vivo and in vitro

  2022cites this paper
• Tanshinone IIA: Pharmacology, total synthesis, and progress in structure-modifications.

  2021cites this paper
• A Review of Medicinal Plants in Cardiovascular Disorders: Benefits and Risks.

  2020cites this paper
• Rottlerin: Structure Modifications and KCNQ1/KCNE1 Ion Channel Activity

  2020cites this paper
• NMR spectroscopy and mass spectrometry in metabolomics analysis of Salvia

  2018cites this paper
• Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics

  2018cites this paper
• A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity

  2018cites this paper
• A novel ventricular restraint device (ASD) repetitively deliver Salvia miltiorrhiza to epicardium have good curative effects in heart failure management.

  2017cites this paper
• Sodium tanshinone IIA sulfonate stimulated Cl− secretion in mouse trachea

  2017cites this paper
• The Role of Biologically Active Ingredients from Natural Drug Treatments for Arrhythmias in Different Mechanisms

  2017cites this paper
• Cardiac Potassium Channels: Physiological Insights for Targeted Therapy

  2017cites this paper
• Cardiac potassium channels: physiological insights for targeted therapy.

  2017cites this paper
• Natural products modulating the hERG channel: heartaches and hope† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7np00014f

  2017cites this paper
• Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy

  2017cites this paper
• Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial

  2017cites this paper
• Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology

  2016cites this paper
• Tanshinone IIA protects H9c2 cells from oxidative stress-induced cell death via microRNA-133 upregulation and Akt activation.

  2016cites this paper
• The Natural Plant Product Rottlerin Activates Kv7.1/KCNE1 Channels

  2016cites this paper
• Mechanisms underlying the cardioprotective effect of Salvianic acid A against isoproterenol-induced myocardial ischemia injury in rats: Possible involvement of L-type calcium channels and myocardial contractility.

  2016cites this paper
• Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica

  2015cites this paper
• A pharmacological basis of herbal medicines for epilepsy.

  2015cites this paper
• Functional Divergence of Diterpene Syntheses in the Medicinal Plant Salvia miltiorrhiza1[OPEN]

  2015cites this paper
• Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.

  2015cites this paper
• Discovery of aroyl piperazine derivatives as IKr & IKs dual inhibitors for cardiac arrhythmia treatment.

  2014cites this paper
• Tanshinone II A inhibits dendritic cell-mediated adaptive immunity: Potential role in anti-atherosclerotic activity

  2014cites this paper
• Enhanced dissolution and stability of Tanshinone IIA base by solid dispersion system with nano-hydroxyapatite

  2014cites this paper
• Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles

  2013cites this paper
• Tanshinone derivatives: a patent review (January 2006 – September 2012)

  2013cites this paper
• New Results on the Pharmacology and Clinical Use of the TCM-Drug Salvia miltiorrhiza

  2013cites this paper
• Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.

  2012cites this paper
• Constituents from Salvia species and their biological activities.

  2012cites this paper
• Cardiovascular actions and therapeutic potential of tanshinone IIA.

  2012cites this paper
• Dingxin Recipe (定心方) prevents ischemia/reperfusion-induced arrhythmias via up-regulating prohibitin and suppressing inflammatory responses

  2012cites this paper
• Release behavior of tanshinone IIA sustained-release pellets based on crack formation theory.

  2012cites this paper
• Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation.

  2012cites this paper
• Update on the slow delayed rectifier potassium current (I(Ks)): role in modulating cardiac function.

  2012cites this paper
• Tanshinone IIA: A Promising Natural Cardioprotective Agent

  2012cites this paper
• Evaluation of pharmacological properties of Danshen compounds by computational and biochemical approaches

  2012cites this paper
• Simultaneous extraction of hydrosoluble phenolic acids and liposoluble tanshinones from Salviae miltiorrhizae radix by an optimized microwave-assisted extraction method

  2012cites this paper
• Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts.

  2011cites this paper
• Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways.

  2011cites this paper
• Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy

  2011cites this paper
• Title Pharmacology of Cardiac Potassium Channels

  2011cites this paper
• Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti‐arrhythmic principle?

  2010cites this paper
• Pharmacology of cardiac potassium channels.

  2010cites this paper
• Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.

  2010cites this paper
• Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3‐kinase/Akt‐dependent pathway in diabetic rats

  2010cites this paper
• Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes

  2010cites this paper
• Dual effects of lipophilic extract of Salvia miltiorrhiza (Danshen) on catecholamine secretion in cultured bovine adrenal medullary cells.

  2009cites this paper
• Tanshinone IIA selectively enhances hyperpolarization-activated cyclic nucleotide-modulated (HCN) channel instantaneous current.

  2009cites this paper
• Effects of sodium tanshinone II A sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro.

  2009cites this paper
• Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA‐1

  2009influential citation
• Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?

  2009cites this paper
• Propofol Depresses Angiotensin II–induced Cell Proliferation in Rat Cardiac Fibroblasts

  2009cites this paper